Use of Interferon-inducible 2',5'-Oligoadenylate-dependent RNase L in The Diagnosis, Prognosis And Treatment of Cancer

Technology
E-196-2001
Patent ID
E-196-2001-0-US-01
Country
US
Application Type
 
Patent Status
Abandoned
Patent Number
 
Publication Number
 
Application Number
60/299,664
IC
NHGRI
Date Filed
Date Issued
 
Patent PDF